Health Management

Lili Brillstein, CEO of BCollaborative and member of the Managed Healthcare Executive® editorial advisory board discusses how the global shut-down and stay-at-home orders due to the COVID-19 pandemic have benefitted us in many ways.

There are a variety of medications being studied for the COVID-19, and the possible treatment landscape is rapidly evolving.

Videoconferencing reduced anxiety and stress among “distance caregivers,” according to the results of randomized trial scheduled to be presented at the annual meeting of the American Society of Clinical Oncology.

Medicaid expansion under the Affordable Care Act resulted in a decrease in cancer mortality rates that translated into 785 fewer cancer deaths in 2017 expansion states, according to results of a study scheduled to be presented at annual meeting of American Society of Clinical Oncology (ASCO), which is now scheduled to be held virtually May 29-31 instead of in Chicago.

Testing remains ongoing in the search for treatment drugs and a vaccine for COVID-19.

Dr. Mark Ruchman, chief medical officer, Versant Health, shares eye safety tips and ways to best stay protected from COVID-19 as guidelines are loosened throughout the country.

The onset of COVID-19 has doubled the percentage of American adults who have tried telemedicine as an alternative to a doctor’s office visit.

Dr. Robert Posner, who specializes in helping people lose weight, offers preparedness advice.

The Advanced Medical Technology Association (AdvaMed) recently announced availability of a new “Code of Ethics Compliance Guidance Related to the COVID-19 Response.”

All across the country, and in fact globally, musculoskeletal (MSK) care has become difficult if not impossible for most patients to access because of the COVID-19 pandemic.

As employers plan to return to the workplace, Mercer survey reveals key considerations from employers’ experience with essential workers and COVID-19.

The FDA recently approved AstraZeneca’s Farxiga (dapagliflozin) for the treatment of heart failure with reduced ejection fraction (HFrEF) in adults with and without type 2 diabetes, marking the first time a drug in a class developed for diabetes was approved for heart failure even if diabetes is not present.

The Whole Person Care pilot program has proven to be essential for communities in California and could potentially do the same in communities around the world.

Two-year follow up of FOURIER study in 22,655 patients confirms neurocognitive safety of very low LDL-C levels using a patient self-survey tool.

Healthcare providers and payers are keeping an eye on unemployment rates across the country and in communities that have been affected the most because the rates will have an effect on the use of medical services and insurance coverage. Here is a look at some of the economies most affected.

Researchers have reported a signicant and positive relationship between the amount of virus present in a throat swab sample and the severity of COVID-19 disease.

The 3D printable mask is the first of its kind to feature a see-through front plate to help patients feel less isolated and is 100% free to download.

The Coronavirus pandemic has served as the most sobering reality and wake-up call to Americans; all starting with our diets.

FDA alerts public not to use chloroquine and hydroxychloroquine to treat COVID-19, as they are not approved to treat anything other than malaria and auto immune disorders.

The collaboration provides patients in the U.S., Europe and Australia with VR Telehealth Kits that include Pico Headsets with Pre-installed Virtual Reality Therapy.

Could the more than 2.5 million firearms purchased in March lead to questionable suicide rate following COVID-19?

Four tips that will help drive medication adherence during COVID-19.

Addressing the disruption in the payer landscape and the adjustments hospitals and medical groups should make to prepare for compelling events so they don't lose patients and revenue.

Associate Editor of Managed Healthcare Executive, Briana Contreras, speaks with Drobac, executive director of Alliance for Connected Care, and a partner with Sirona Strategies, in Washington, DC, about the recent rise of telehealth in response to COVID-19.

Healthcare analytics company leverages unmatched data set to fuel robust COVID-19 Resource Center.

The lung injury related to the coronavirus is similar to but not high altitude pulmonary edema like many perceive.

Empa and ETH Zurich researchers usually work on measuring, analyzing, and reducing airborne pollutants, however, their new focus: a sensor that can quickly detect SARS-CoV-2.

The coronavirus pandemic has been a seismic disturbance however in a post-COVID-19 environment transformational healthcare trends will be back with a vengeance.

By almost any measure, these are good times for Medicare Advantage. Enrollment is growing, the number of insurers in the market is increasing, and gross margins are higher than in other health insurance markets.

With the use of virtual and telemedmedicine services increasing, health plans must continually use the data available through digital channels to listen to and learn from members, adjust content to answer their questions, and respond to their needs, to build both a lasting member relationship and enhance future digital capabilities.